SymBiosis Capital Partners, LLC
BENTONVILLE AR · SEC CIK 0002006045
$5,276.99万2026Q1 申报市值
6持仓数
100.0%前十大占比 · 第一大 55.8%
1 / 6新建仓 / 清仓
26Q1
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
WVE 新建仓+$543.75万
2026Q1 卖出最多 按季末市值估算
VSTM 清仓-$1,544.00万
Aldeyra Therapeu 清仓-$1,323.49万
PGEN 清仓-$1,254.00万
NUVB 清仓-$1,120.00万
Aardvark Therape 清仓-$625.53万
2026Q1 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| EVMN | Evommune, Inc. | $2,944.51万 | 55.80% | 1,280,778 | 0 | 0.0% | — | 不变 |
| IVA | Inventiva S.A. | $1,306.47万 | 24.76% | 2,354,000 | -246,000 | -9.5% | -$136.53万 | 减仓 |
| WVE | Wave Life Sciences Ltd. | $543.75万 | 10.30% | 750,000 | 750,000 | — | $543.75万 | 新建仓 |
| — | Rani Therapeutics Holdings, Inc. | $269.49万 | 5.11% | 3,667,585 | -2,632,415 | -41.8% | -$193.43万 | 减仓 |
| — | Clene Nanomedicine Inc. | $212.53万 | 4.03% | 431,094 | -339,401 | -44.0% | -$167.32万 | 减仓 |
| — | Surrozen, Inc. | $2,400 | 0.00% | 150,000 | 0 | 0.0% | — | 不变 |
| VSTM | Verastem Inc | $0 | 0.00% | 0 | -2,000,000 | -100.0% | -$1,544.00万 | 清仓 |
| — | Aldeyra Therapeutics Inc | $0 | 0.00% | 0 | -2,555,000 | -100.0% | -$1,323.49万 | 清仓 |
| PGEN | Precigen Inc | $0 | 0.00% | 0 | -3,000,000 | -100.0% | -$1,254.00万 | 清仓 |
| NUVB | Nuvation Bio Inc | $0 | 0.00% | 0 | -1,250,000 | -100.0% | -$1,120.00万 | 清仓 |
| — | Aardvark Therapeutics, Inc. | $0 | 0.00% | 0 | -476,595 | -100.0% | -$625.53万 | 清仓 |
| — | Generation Bio Co | $0 | 0.00% | 0 | -665,000 | -100.0% | -$377.72万 | 清仓 |